PF3D7_1034700

PF3D7_1034700 encodes a class I ADP-ribosylation factor (PfARF1) that functions as a GDP/GTP-binding small GTPase regulating vesicular export from the endoplasmic reticulum in blood-stage Plasmodium falciparum (PMID:8954160, PMID:33604307). In vitro, recombinant PfARF1 is purified with bound GDP, binds GTP with first-order kinetics, lacks detectable intrinsic GTPase activity, and stimulates cholera-toxin-catalyzed ADP-ribosyltransferase activity, defining it as a class I ARF family member (PMID:8954160); its GDP-bound conformation was resolved crystallographically at 2.5 Å and resembles mammalian class I ARF1 (PMID:21045287). N-myristoylated PfARF1 localizes to the Golgi via its N-terminus, and its N-terminus alone is insufficient for parasite-plasma-membrane targeting or translocation into the parasitophorous vacuole (PMID:25909331). PfARF1 associates with PfRab5b and occupies ER subdomains distinct from PfRab1b, and both active and inactive PfARF1 mutants perturb ER exit, blocking trafficking of the PEXEL-negative PfAK2 to the parasitophorous vacuole membrane and reducing export of the PEXEL-positive protein Rifin (PMID:33604307). Biochemically, recombinant PfARF1 acts upstream of phosphoinositide signalling by activating the parasite's unique bifunctional PIP5K to promote PtdIns(4,5)P2 synthesis (PMID:19171150).

1. 1996 High

   Establishing whether the P. falciparum ARF gene product is a functional nucleotide-binding factor was the first step to assigning it to the ARF family; biochemical reconstitution defined its enzymatic behavior.

   Evidence recombinant expression in E. coli with GDP-binding, GTP-binding kinetics, and cholera-toxin ADP-ribosyltransferase stimulation assays

   PMID:8954160

   Open questions at the time

   • No intrinsic GTPase activity detected, leaving the GAP/GEF machinery that cycles PfARF1 in vivo unidentified
   • In vitro classification does not establish cellular function or localization
2. 1997 Low

   Cloning of ARF and ARF-like genes established the composition of the parasite ARF family, providing the sequence framework in which PF3D7_1034700 is a distinct member.

   Evidence gene cloning, sequencing, and characterization of P. falciparum ARF/ARF-like genes

   PMID:9084044 PMID:9247933

   Open questions at the time

   • Abstracts unavailable; specific attribution to PF3D7_1034700 versus sibling family members cannot be resolved
   • No functional data beyond sequence identification
3. 2009 Medium

   Whether PfARF1 links to phosphoinositide signalling was unknown; reconstitution placed it upstream of PtdIns(4,5)P2 synthesis.

   Evidence in vitro kinase activation assay with recombinant ARF1 and recombinant bifunctional PIP5K

   PMID:19171150

   Open questions at the time

   • Single lab, single in vitro method; the interaction has not been validated in the cellular context
   • Physiological consequence of PIP5K activation for parasite trafficking not established
4. 2010 High

   The structural basis of PfARF1 nucleotide binding was undefined; a crystal structure resolved the GDP-bound conformation and confirmed class I ARF architecture.

   Evidence X-ray crystallography at 2.5 Å of the GDP-bound state

   PMID:21045287

   Open questions at the time

   • Only the GDP-bound (inactive) state was captured; the GTP-bound active conformation and any parasite-specific interaction surfaces remain unresolved
5. 2015 Medium

   Where PfARF1 acts in the parasite and what dictates its targeting was open; localization and chimera dissection assigned it to the Golgi and mapped targeting determinants to the N-terminus.

   Evidence GFP-tagging, fluorescence microscopy, chimeric protein analysis, and subcellular fractionation in blood-stage parasites

   PMID:25909331

   Open questions at the time

   • N-terminus alone directs Golgi localization but is insufficient for plasma-membrane targeting/translocation; the additional recruitment machinery is not identified
   • Single lab, overexpression-based readout
6. 2021 High

   The cargo and partners of PfARF1 in ER export were unknown; interaction mapping and mutant trafficking assays placed it as a regulator of ER exit for both PEXEL-negative and PEXEL-positive cargo.

   Evidence reciprocal Co-IP with mass spectrometry, super-resolution microscopy, and active/inactive mutant overexpression with PfAK2 and Rifin trafficking readouts

   PMID:33604307

   Open questions at the time

   • Mechanism by which PfARF1 discriminates or acts on PEXEL-positive versus PEXEL-negative cargo is unresolved
   • Functional relationship between the PfRab5b association and the trafficking phenotype not dissected
   • Dominant-mutant overexpression does not establish endogenous requirement

• The nucleotide-cycling machinery (GEFs/GAPs), the physiological coupling between PfARF1-driven PIP5K activation and its ER-export function, and its endogenous requirement in the parasite life cycle remain unestablished.
• No PfARF1 GEF or GAP identified
• In vitro PIP5K activation and in-cell ER-export roles have not been integrated into one mechanistic pathway
• No loss-of-function/knockout phenotype for endogenous PfARF1 reported in the corpus